Atomi Financial Group, Inc. Neurocrine Biosciences Inc Transaction History
Atomi Financial Group, Inc.
- $2.65 Trillion
- Q2 2025
A detailed history of Atomi Financial Group, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Atomi Financial Group, Inc. holds 1,838 shares of NBIX stock, worth $253,717. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,838Holding current value
$253,717% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
681Shares Held
102MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$1.96 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.35 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$768 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$617 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$426 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.2B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...